概述
Breast cancer is the most commonly diagnosed cancer in women worldwide. It develops in the cells of the breast tissue, most commonly in the ducts (ductal carcinoma) or the milk-producing glands called lobules (lobular carcinoma). While breast cancer predominantly affects women, it can also occur in men. Early detection through screening and advances in treatment have significantly improved survival rates. Cuba's oncology centers provide comprehensive evaluation and treatment programs for international patients with breast cancer, including access to immunotherapy approaches developed by Cuba's biotechnology sector.
症状
- A new lump or mass in the breast or underarm
- Changes in breast size, shape, or contour
- Skin changes on the breast (dimpling, puckering, redness)
- Nipple changes (inversion, discharge, or scaling)
- Swelling or thickening of part of the breast
- Breast or nipple pain
- Swollen lymph nodes under the arm or near the collarbone
风险因素
- Being female (though men can also develop breast cancer)
- Increasing age
- Family history of breast cancer (BRCA1/BRCA2 mutations)
- Personal history of breast conditions or breast cancer
- Early menstruation (before age 12) or late menopause (after 55)
- Having no children or first pregnancy after age 30
- Hormone replacement therapy
- Obesity and physical inactivity
- Alcohol consumption
- Previous radiation exposure to the chest
诊断
Diagnosis involves a combination of imaging and tissue analysis. Mammography (breast X-ray) is the primary screening tool, followed by breast ultrasound for further detail. MRI may be used for high-risk patients or to evaluate the extent of disease. A biopsy (core needle or surgical) confirms the diagnosis, and the tissue is analyzed for hormone receptor status (ER, PR), HER2 expression, and Ki-67 proliferation index — markers that help determine how the cancer will behave and which treatments may work best. Cuban oncology centers use comprehensive molecular profiling to guide personalized treatment plans.
疾病分期
Breast cancer staging follows the TNM system. Stage 0 (carcinoma in situ): Abnormal cells are present but have not spread. Stage I: The tumor is 2cm or smaller and has not spread to lymph nodes. Stage II: The tumor is 2-5cm and/or has spread to a few nearby lymph nodes. Stage III: The tumor is larger or has spread to more lymph nodes; may involve the chest wall or skin. Stage IV: The cancer has spread to distant organs (bones, liver, lungs, brain). Treatment approaches vary significantly by stage and biomarker profile.
标准治疗方案
surgery
Surgical options include lumpectomy (breast-conserving surgery) and mastectomy (removal of the breast). Sentinel lymph node biopsy or axillary lymph node dissection may be performed to check lymph node involvement. Reconstructive surgery may be offered after mastectomy.
chemotherapy
Chemotherapy may be used before surgery (neoadjuvant, to shrink tumors) or after surgery (adjuvant, to reduce recurrence risk). Regimens are tailored based on the cancer's molecular profile, stage, and the patient's overall health.
radiotherapy
Radiation therapy is typically used after lumpectomy to destroy any remaining cancer cells and reduce recurrence risk. It may also be used after mastectomy for high-risk cases or for palliative care in advanced stages.
targeted
Targeted therapies include HER2 inhibitors (trastuzumab, pertuzumab) for HER2-positive breast cancer, CDK4/6 inhibitors for hormone receptor-positive cancers, and PARP inhibitors for BRCA-mutated cancers. Molecular testing determines which targeted therapies may be appropriate.
immunotherapy
Immunotherapy approaches, including immune checkpoint inhibitors, may be considered for triple-negative breast cancer (TNBC) and other subtypes. Cuba's biotechnology research includes investigation of immunotherapeutic approaches that may be considered as part of a comprehensive treatment program for eligible international patients.
supportive
Supportive care includes hormonal therapy (tamoxifen, aromatase inhibitors) for hormone receptor-positive cancers, pain management, nutritional counseling, psychological support, and rehabilitation services.
Cuba的潜在治疗方法
Cuba's approach to breast cancer involves comprehensive evaluation by a multidisciplinary oncology team, including medical oncologists, radiation oncologists, surgeons, and pathologists. For international patients, the process begins with a thorough review of medical records to determine the most appropriate treatment strategy. Cuba's biotechnology sector has developed immunotherapeutic approaches that may be considered as part of a personalized treatment program. The oncology team evaluates each case individually, considering the cancer's molecular profile, stage, prior treatments, and the patient's overall health to determine whether Cuban therapies may be appropriate.
Explore Cuba's Treatment for This Condition
Cuba offers specialized treatment programs for this condition. Learn more about the therapy, eligibility, and how to request a medical evaluation.
可能符合条件的人群
Whether breast cancer treatment in Cuba is right for you is determined through a medical review of your diagnosis, staging, biomarker profile (ER, PR, HER2, Ki-67), prior treatments, and overall health. Each case is evaluated individually by the Cuban oncology team. Patients must provide complete medical records including pathology reports with biomarker results, imaging, and treatment summaries for review before a treatment plan can be proposed.
所需医疗文件
- Biopsy report with hormone receptor status (ER, PR, HER2, Ki-67)
- Recent mammography, breast ultrasound, and/or breast MRI
- CT and/or PET imaging for staging
- Your oncologist's treatment summary including all prior surgeries, chemotherapy, and radiotherapy
- Current medication list including hormonal therapy
- Recent general blood panel (blood count, liver and kidney function)
- BRCA1/BRCA2 genetic test results if available
如何申请医疗评估
提交您的病历供我们肿瘤团队审核。如果治疗方案可能适合您的情况，将为您制定个性化方案。只有在医疗团队确认符合条件后，您才需前往Cuba。
Frequently Asked Questions
Can international patients receive breast cancer treatment in Cuba?
Yes. International patients may be evaluated for breast cancer treatment through SMC Salud. The process begins with a medical review of your records, including your pathology reports, imaging, and treatment history. If the oncology team determines that treatment may be appropriate, a personalized plan is developed. Contact us to submit your medical documents for review.
What immunotherapy options are available for breast cancer in Cuba?
Cuba's biotechnology research includes immunotherapeutic approaches that may be considered for certain breast cancer subtypes, particularly triple-negative breast cancer. However, eligibility depends on the individual's specific diagnosis, molecular profile, and clinical condition. The oncology team determines suitability after reviewing your complete medical records.
Can breast cancer be cured in Cuba?
No treatment can guarantee a cure for breast cancer. Outcomes vary significantly by stage, molecular subtype, and individual patient factors. Cuba's oncology centers provide evidence-based treatment programs that may include surgery, chemotherapy, radiotherapy, targeted therapy, and immunotherapy approaches. Our oncology team evaluates each case to provide realistic expectations based on the patient's specific situation.
How do I request a medical evaluation for breast cancer treatment?
You can request a medical evaluation by submitting your medical documents through our patient intake form. You will need your pathology report with biomarker results, imaging studies, treatment summary, and current medications. Our international patient services team will guide you through the process.
Can family members accompany me during treatment in Cuba?
Yes, family members may accompany patients during treatment in Cuba. SMC Salud's international patient services team assists with accommodation, travel arrangements, and all logistics for both patients and their companions.
参考资料
- World Health Organization — Breast Cancer Fact Sheet.
- American Cancer Society — Breast Cancer Treatment Guidelines.
- Cuba's Center of Molecular Immunology (CIM) — Immunotherapy Research Publications.
医疗免责声明
本页面提供的医疗信息仅供一般参考，不能替代专业医疗建议、诊断或治疗。如有任何与医疗状况相关的问题，请务必向合格的医疗专业人员寻求建议。任何治疗的适用资格取决于患者的临床状况，并由主治医疗团队决定。
此内容已由资深医师进行医学审核，并遵循 SMC Salud 健康信息编辑政策。医学内容仅供参考，不能替代专业的医疗建议。